Search research articles
Contact Us
Filters
Showing results (41-50 of 236) with videos related to
Page
of 24
Sort By:
Clinical Chemistry
|
February 1, 1981
In vitro interactions between beta-lactam antibiotics and tobramycin
D J Edwards, J J Schentag
American Journal of Hospital Pharmacy
|
June 1, 1981
Creatinine clearance predictions in acutely ill patients
M M Chrymko, J J Schentag
Current Opinion in Infectious Diseases
|
October 13, 2006
Pharmacokinetic and pharmacodynamic modelling of antibiotic therapy
P A Moise, J J Schentag
Chest
|
December 24, 1997
Antibiotic selection and dosing for the treatment of acute exacerbations of COPD
J J Schentag, G S Tillotson
The Journal of Pediatrics
|
October 1, 1986
Pharmacokinetics and nephrotoxicity of continuous intravenous infusion of gentamicin in low birth weight infants
G P Giacoia, J J Schentag
Infection Control and Hospital Epidemiology
|
February 2, 2000
Potential role of pharmacokinetics, pharmacodynamics, and computerized databases in controlling bacterial resistance
J M Hyatt, J J Schentag
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
August 1, 1988
Lack of effect of cimetidine on the metabolism of quinidine: effect on renal clearance
B G Hardy, J J Schentag
Drug Intelligence & Clinical Pharmacy
|
February 1, 1987
Potential impact of quantitative susceptibility tests on the design of aminoglycoside dosing regimens
J P McCormack, J J Schentag
Antimicrobial Agents and Chemotherapy
|
November 1, 1982
Two-compartment comparison of gentamicin and tobramycin in normal volunteers
M Adelman, E Evans, J J Schentag
Clinical Pharmacology and Therapeutics
|
October 1, 1982
Relationship between concentration and anticoagulant effect of heparin in plasma of hospitalized patients: magnitude and predictability of interindividual differences
L R Whitfield, J J Schentag, G Levy
Page
of 24
Search research articles
Search
Showing results (41-50 of 236) with videos related to
Sort By:
Page
of 24
Clinical Chemistry
|
February 1, 1981
In vitro interactions between beta-lactam antibiotics and tobramycin
D J Edwards, J J Schentag
American Journal of Hospital Pharmacy
|
June 1, 1981
Creatinine clearance predictions in acutely ill patients
M M Chrymko, J J Schentag
Current Opinion in Infectious Diseases
|
October 13, 2006
Pharmacokinetic and pharmacodynamic modelling of antibiotic therapy
P A Moise, J J Schentag
Chest
|
December 24, 1997
Antibiotic selection and dosing for the treatment of acute exacerbations of COPD
J J Schentag, G S Tillotson
The Journal of Pediatrics
|
October 1, 1986
Pharmacokinetics and nephrotoxicity of continuous intravenous infusion of gentamicin in low birth weight infants
G P Giacoia, J J Schentag
Infection Control and Hospital Epidemiology
|
February 2, 2000
Potential role of pharmacokinetics, pharmacodynamics, and computerized databases in controlling bacterial resistance
J M Hyatt, J J Schentag
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
August 1, 1988
Lack of effect of cimetidine on the metabolism of quinidine: effect on renal clearance
B G Hardy, J J Schentag
Drug Intelligence & Clinical Pharmacy
|
February 1, 1987
Potential impact of quantitative susceptibility tests on the design of aminoglycoside dosing regimens
J P McCormack, J J Schentag
Antimicrobial Agents and Chemotherapy
|
November 1, 1982
Two-compartment comparison of gentamicin and tobramycin in normal volunteers
M Adelman, E Evans, J J Schentag
Clinical Pharmacology and Therapeutics
|
October 1, 1982
Relationship between concentration and anticoagulant effect of heparin in plasma of hospitalized patients: magnitude and predictability of interindividual differences
L R Whitfield, J J Schentag, G Levy
Page
of 24